ABI3 and Alzheimer disease: Using the Mayo Clinic RNAseq data [19], we previously showed that both ABI3 and PLCG2 had higher expression levels in the temporal cortex of AD brains compared to controls, although the significance was abolished upon adjusting for CNS cell type markers [1].